%20(1).jpg)
A condition in Need of a Scalable Treatment
Chronic rhinosinusitis (CRS) is a persistent inflammation of the nasal passages and sinuses lasting 12 weeks or longer. Recurrent Acute Rhinosinusitis (RARS) is a condition where patients have 4 or more rhinosinusitis episodes per year, without persistent symptoms between episodes. It occurs when the sinuses become blocked and filled with fluid, creating an environment for bacterial growth and infection. It affects approx. 8-15% of the global population. If treated inefficiently, CRS negatively impacts patients’ quality of life, due to chronic discomfort and long-term respiratory issues.
Common symptoms include:
To be diagnosed with CRS, patients must experience at least two of these symptoms for 12 weeks or more.
.jpg)
.jpg)
.jpg)
The Treatment Gap & a New Approach to Balloon Sinuplasty
Treatment for Chronic Rhinosinusitis (CRS) often begins with medical management (irrigation, corticosteroids, and decongestants). However, these treatments fail when structural issues prevent proper sinus drainage, leaving many patients in need of a surgical solution.
Balloon sinuplasty (BSP) is a proven, minimally invasive technique that safely opens blocked sinus pathways, providing quick and long-term relief. It is especially suitable for RARS and cases of CRS without nasal polyposis. However, current balloon sinuplasty technology is hamperd by the need for multiple medical personnel, anesthesia, and sometime financial resources, limiting access for both clinics and patients.
Our Solution: Scalable, Efficient, and More Accessible CRS Treatment
At Venteus, we are developing an innovative medical device that transforms CRS treatment by streamlining the surgical process, reducing procedural complexity, and expanding access. What Characterizes Our Approach:
Speed
Human resource savings
Increased efficiency
Lower Costs
Better safety
Better scalability for the Healthcare System
By eliminating the inefficiencies of current CRS interventions, our solution revolutionizes care for both patients and providers, creating a more sustainable and cost-effective treatment pathway.
Frequently asked questions
Why is CRS difficult to treat?
CRS and RARS are chronic and recurrent conditions that may not respond well to medication alone. Current standard surgical interventions (CAS-FESS) are effective but require complex procedures, anesthesia, and a large medical team, making them resource-heavy and difficult to scale. Furthermore, the CAS FESS procedure is significantly more invasive than balloon sinuplasty and imposes more risks and longer recovery time for the patients.
How Does Balloon Sinuplasty Work?
Balloon sinuplasty is a minimally invasive procedure where a small balloon is inserted through the nose into the blocked sinus passage and gently inflated to widen the natural openings of the sinuses, restoring normal drainage and relieving chronic inflammation. However, balloon sinuplasty may require anesthesia and multiple medical personnel, making it a resource-intensive procedure for clinics and a demanding experience for patients.
Who benefits from this improvement in CRS and RARS treatement?
- Patients with chronic rhinosinusitis gain faster relief without complex surgery. The streamlined procedure lowers costs, shortens recovery times, and expands access to balloon sinuplasty in outpatient settings.
- Patients with recurrent acute rhinosinusitis RARS have shown significant improvement from balloon sinuplasty compared to medical treatments alone.
- Doctors benefit from a simpler, more efficient procedure that reduces reliance on multiple staff members and minimizes surgical strain. With improved workflow and fewer logistical barriers, specialists can treat more patients with greater ease and precision.
- For clinics and healthcare providers, increased efficiency means lower operational costs and higher patient throughput. Hospitals also gain by freeing up operating theaters and reducing treatment expenses, making CRS care more scalable and widely available.
By removing barriers to effective treatment, this solution enhances patient outcomes while improving efficiency for doctors and healthcare systems alike.
How will this device impact clinics?
By streamlining the procedure, clinics can treat more patients efficiently, reduce operational costs, and expand their service offerings without requiring extensive staff involvement.